Summary - IMCR - NASDAQ - Weiss Ratings

E

Immunocore Holdings plc IMCR

$37.88 $1.714.73% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$23.15 - $40.53

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Growth Picks: 3 Low-Cost Stocks That Could Double in Value

10/27/2025 - MarketBeat

Immunocore (NASDAQ:IMCR) Shares Gap Down - Here's What Happened

12/3/2025 - MarketBeat

Immunocore Holdings plc (IMCR, $36.17) entered Downtrend as Momentum indicator drops below 0 level on Dec 02, 2025

12/3/2025 - Tickeron - Stocks

Immunocore Holdings (IMCR, $36.17) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 2, 2025

12/3/2025 - Tickeron - Stocks

Immunocore Holdings (IMCR, $37.59) RSI Indicator left the overbought zone on December 01, 2025

12/2/2025 - Tickeron - Stocks

Immunocore (NASDAQ:IMCR) Sets New 1-Year High - Still a Buy?

11/27/2025 - MarketBeat

H.C. Wainwright Reaffirms Their Buy Rating on Immunocore Holdings (IMCR)

11/21/2025 - TipRanks Financial Blog

Immunocore (NASDAQ:IMCR) Reaches New 52-Week High - What's Next?

11/21/2025 - MarketBeat

Immunocore Holdings (IMCR, $38.06) RSI Indicator left the overbought zone on November 18, 2025

11/19/2025 - Tickeron - Stocks

A Fresh Look at Immunocore Holdings (NasdaqGS:IMCR) Valuation After Positive Phase 1 Data for HBV Therapy

11/18/2025 - Simply Wall St

Immunocore Holdings (IMCR) Is Up 7.3% After Promising Early Hepatitis B Immunotherapy Results and Revenue Gains

11/17/2025 - Simply Wall St

Fiera Capital Corp Purchases 7,924 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR

11/15/2025 - MarketBeat

Fox Run Management L.L.C. Invests $372,000 in Immunocore Holdings PLC Sponsored ADR $IMCR

11/14/2025 - MarketBeat

Immunocore (NASDAQ:IMCR) Price Target Raised to $36.00 at Morgan Stanley

11/11/2025 - MarketBeat

Immunocore Holdings (IMCR, $35) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 10, 2025

11/11/2025 - Tickeron - Stocks

Immunocore Holdings (IMCR, $35) price moved above its 50-day Moving Average on November 10, 2025

11/11/2025 - Tickeron - Stocks

Immunocore (NasdaqGS:IMCR): Assessing Valuation After Promising Hepatitis B Trial Results and Bullish Analyst Ratings

11/11/2025 - Simply Wall St

IMCR: Morgan Stanley Adjusts Price Target for Immunocore Holdings IMCR Stock News

11/10/2025 - GuruFocus

Immunocore to present at upcoming investor conferences

11/10/2025 - Globe Newswire

Immunocore Holdings (IMCR) Gets a Hold from Mizuho Securities

11/10/2025 - TipRanks Financial Blog

Analysts Are Bullish on These Healthcare Stocks: LENZ Therapeutics (LENZ), Immunocore Holdings (IMCR)

11/10/2025 - TipRanks Financial Blog

Immunocore (NASDAQ:IMCR) Announces Earnings Results

11/9/2025 - MarketBeat

Positive Hepatitis B Trial Data Might Change the Case for Investing in Immunocore Holdings (IMCR)

11/9/2025 - Simply Wall St

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Immunocore Holdings (IMCR)

11/8/2025 - TipRanks Financial Blog

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver Meeting

11/7/2025 - Globe Newswire

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Thursday, November 6, 2025

Period Date

Tuesday, September 30, 2025

Next Filing

Week of Feb 23 and 27 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

--

52-week Low

Apr 09, 2025 - $23.15

52-week High

Nov 28, 2025 - $40.53

Valuation

Market Cap

$1.83B - Small Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

www.immunocore.com

Phone Number

44 12 3543 8600

Address

92 Park Drive
Abingdon, OX14 4RY

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company... more